investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
+
-
Project leads
Collaborators
Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions
Javier Adachi
7 Collaborator(s)
Funding source
University of Texas MD Anderson Cancer Center
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Keiichi Furukawa
St. Luke's International University
Tokyo, Japan
Jose Munita
Clínica Alemana
Santiago, Chile
George Weinstock
Jackson Laboratory
Bar Harbor, United States
Cesar Arias
University of Texas Health Science Center at Houston
Houston, United States
Aline El Zakhem
American University of Beirut
Beirut, Lebanon
Nelson Hamerschlak
Albert Einstein Hospital
São Paulo, Brazil
Javier Adachi
University of Texas MD Anderson Cancer Center
Houston, United States
Carlos Vallejos
Instituto Nacional de Enfermedades Neoplásicas
Lima, Peru
Oncosalud-AUNA
Lima, Peru
Related projects
Reuben Kapur
Role of p21 Activated Kinase in Leukemogenesis
Leukaemia
Hematology and hematologic malignancies
Stephanie J Lee
Improving Outcomes Assessment in Chronic Graft versus Host Disease
Leukaemia
Hematology and hematologic malignancies
Martine Extermann
Decision Models to Compare Treatments in Older Patients with AML
Leukaemia
Hematology and hematologic malignancies
Michele S Redell
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
Leukaemia
Hematology and hematologic malignancies
Nicola J Camp
Genetic Epidemiology of Chronic Lymphocytic Leukemia
Leukaemia
Hematology and hematologic malignancies
Thomas J O'Hare
Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia
Leukaemia
Hematology and hematologic malignancies
Catherine Ju-Ying Wu
(PQD1) Impact of Cytotoxic and Targeted Therapy on Clonal Evolution of CLL
Leukaemia
Hematology and hematologic malignancies
Ya-Huei Kuo
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
Leukaemia
Hematology and hematologic malignancies
Targeting BCL6 in Tyrosine Kinase-Driven Leukemia
Leukaemia
Hematology and hematologic malignancies